Beryllium induces apoptosis in human lung macrophages

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 19, Issue 2, 2002, Pages 101-113

  Kittle, Lori A ^a   Sawyer, Richard T ^a   Fadok, Valerie A ^a   Maier, Lisa A ^a   Newman, Lee S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Antigen persistence; Apoptosis; Beryllium; Beryllium disease; Granulomatous inflammation; Granulomatous lung disease; Macrophage

Indexed keywords

BERYLLIUM; CASPASE; CD14 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BERYLLIOSIS; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; NICK END LABELING; OCCUPATIONAL EXPOSURE; PATHOLOGY;

ANTIGENS, CD14; APOPTOSIS; BERYLLIOSIS; BERYLLIUM; BRONCHOALVEOLAR LAVAGE FLUID; COMPARATIVE STUDY; FEMALE; HUMAN; IN SITU NICK-END LABELING; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGE; OCCUPATIONAL EXPOSURE; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR; HUMANS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035986953     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Beryllium disease
2. Pathologic and immunologic alterations in early stages of beryllium disease: Re-examination of disease definition and natural history
3. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease
4. Beryllium disease and sarcoidosis. Clinical and laboratory links
5. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis
6. Beryllium-stimulated in vitro migration of peripheral blood lymphocytes
7. Beryllium induces IL-2 and IFN-γ in berylliosis
8. Beryllium-stimulated release of tumor necrosis factor-α, interleukin-6, and their soluble receptors in chronic beryllium disease
9. Beryllium-stimulated production of tumor necrosis factor-α by a mouse hybrid macrophage cell line
10. Beryllium-induced apoptosis in macrophage cell lines
11. Apoptosis control by death and decoy receptors
12. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of disease
13. Revisiting the role of tumor necrosis factor-α and the response to surgical injury and inflammation
14. Monocyte CD14: A multifunctional receptor engaged in apoptosis from both sides
15. Beryllium stimulation does not activate transcription factors in a mouse hybrid macrophage cell line
16. Role of CD14 in macrophage TNF-α regulation in chronic beryllium disease
17. Epidemiology Standardization Project
18. Idiopathic pulmonary fibrosis: Pretreatment bronchoalveolar lavage cellular constituents and their relationship with lung histopathology and clinical response to therapy
19. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils
20. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89
21. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-α and interleukin-6 but not interleukin-1β
22. Extension of multiple range tests to group means with unequal numbers of replications
23. Epidemiology of beryllium sensitization and disease in nuclear workers
24. Beryllium disease screening in the ceramics industry. Blood lymphocyte performance and exposure-disease relations
25. Reactive oxygen species regulate activation-induced T cell apoptosis
26. Cadmium suppresses apoptosis induced by chromium
27. Induction of apoptosis in human T-cells by organomercuric compounds: A flow cytometric analysis
28. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: Evidence of mitochondrial dysfunction
29. DNA cleavage in rat liver nuclei activated by Mg2+ or Ca2+ + Mg2+ is inhibited by a variety of structurally unrelated inhibitors
30. Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro
31. Chelation of intracellular zinc triggers apoptosis in mature thymocytes
32. A role for metals and free radicals in the induction of apoptosis in thymocytes
33. A reappraisal of the role of zinc in life and death decisions of cells
34. Copper, but not iron, enhances apoptosis-inducing activity of antioxidants
35. Induction of differentiation and apoptosis by dithizone in human myeloid leukemia cells
36. Transition-metal complexes of isatin-beta-thiosemicarbazone. X-ray crystal structure of two nickel complexes
37. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: Regulation by metal ions
38. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis
39. Silica-induced apoptosis in alveolar macrophages and granulomatous cells in vivo
40. Regulation of human monocyte apoptosis by CD14 molecule
41. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines
42. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes
43. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis
44. Shedding as a mechanism of down modulation of CD14 on stimulated human monocytes
45. Biochemistry and expression of myelmnonocytic antigens
46. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage
47. Isolation characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23
48. Antigens on human monocytes identified by monoclonal antibodies
49. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease
50. Alternative pathways of apoptosis induced by methylprednisolone and valinomycin analyzed by flow cytometry
51. Dexamethasone, β-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets
52. Thymus-derived glucocorticoids regulate antigen-specific positive-selection
53. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes
54. KipI
55. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling
56. p53-independent upregulation of KILLER/DR5 TRAIL, receptor expression by glucocorticoids and interferon-γ
57. Glucocorticoids induce apoptosis in human monocytes: Potential role of 1L-1β
58. Role of CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis
59. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis
60. Human CD14 mediates recognition and phagocytosis of apoptotic cells
61. A receptor for phosphatidylserine-specific clearance of apoptotic cells
62. The uptake of beryllium by alveolar macrophage
63. Apoptotic cell removal
64. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of Proteases
65. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells
66. Beryllium